Various subpopulations of myeloid cells (monocytes, VEGFR-1+CD14 and Tie2+CD14 cells) were defined by cytometry in the peripheral blood of RCC patients (Figure 2). This evidence concerns the gene CD14 and renal cell carcinoma.